Prevalence and Impact of Central Sleep Apnea in Heart Failure

Sleep Medicine Clinics

Volumn 2, Issue 4, 2007, Pages 615-621

  Lévy, Patrick ^a,b   Pépin, Jean Louis ^a,b   Tamisier, Renaud ^a,b   Neuder, Yannick ^c   Baguet, Jean Philippe ^c   Javaheri, Shahrokh ^d  

^a INSERM   (France)

^b EFCR   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d Sleepcare Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

CARDIAC RESYNCHRONIZATION THERAPY; CENTRAL SLEEP APNEA SYNDROME; CORONARY ARTERY BYPASS SURGERY; DISEASE ASSOCIATION; DISEASE COURSE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOXEMIA; MORTALITY; MULTICHANNEL RECORDER; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYMPATHETIC TONE;

EID: 57749120110     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2007.08.001     Document Type: Review

References (43)

1. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American college of cardiology/American Heart Association task force on practice guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American college of chest physicians and the international society for heart and lung transplantation: endorsed by the Heart rhythm society. Circulation 112 (2005) e154-e235
2. Jessup M., and Brozena S. Heart failure. N Engl J Med 348 (2003) 2007-2018
3. Ceia F., Fonseca C., Mota T., et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail 4 (2002) 531-539
4. Hoes A.W., Mosterd A., and Grobbee D.E. An epidemic of heart failure? Recent evidence from Europe. Eur Heart J 19 Suppl L (1998) L2-L9
5. van der Meer P., Voors A.A., Lipsic E., et al. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J Am Coll Cardiol 44 (2004) 63-67
6. Pocock S.J., Wang D., Pfeffer M.A., et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27 (2006) 65-75
7. Siirila-Waris K., Lassus J., Melin J., et al. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J 27 (2006) 3011-3017
8. Schaufelberger M., Swedberg K., Koster M., et al. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J 25 (2004) 300-307
9. Muntwyler J., Abetel G., Gruner C., et al. One-year mortality among unselected outpatients with heart failure. Eur Heart J 23 (2002) 1861-1866
10. Martinez-Selles M., Garcia Robles J.A., Prieto L., et al. Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure. Eur Heart J 24 (2003) 2046-2053
11. Javaheri S., Parker T.J., Liming J.D., et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97 (1998) 2154-2159
12. Tremel F., Pepin J.L., Veale D., et al. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 20 (1999) 1201-1209
13. Sin D.D., Fitzgerald F., Parker J.D., et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160 (1999) 1101-1106
14. Lofaso F., Verschueren P., Rande J.L., et al. Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest 106 (1994) 1689-1694
15. Findley L.J., Zwillich C.W., Ancoli-Israel S., et al. Cheyne-Stokes breathing during sleep in patients with left ventricular heart failure. South Med J 78 (1985) 11-15
16. Lanfranchi P.A., Braghiroli A., Bosimini E., et al. Prognostic value of nocturnal Cheyne-stokes respiration in chronic heart failure. Circulation 99 (1999) 1435-1440
17. Javaheri S., Shukla R., Zeigler H., et al. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 49 (2007) 2028-2034
18. Roebuck T., Solin P., Kaye D.M., et al. Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J 23 (2004) 735-740
19. Andreas S., Hagenah G., Moller C., et al. Cheyne-Stokes respiration and prognosis in congestive heart failure. Am J Cardiol 78 (1996) 1260-1264
20. Javaheri S., Parker T.J., Wexler L., et al. Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 122 (1995) 487-492
21. Lanfranchi P.A., Somers V.K., Braghiroli A., et al. Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation 107 (2003) 727-732
22. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 106 (2006) 21-28
23. Bradley T.D., Logan A.G., Kimoff R.J., et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353 (2005) 2025-2033
24. Ferrier K., Campbell A., Yee B., et al. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 128 (2005) 2116-2122
25. Schulz R., Blau A., Borgel J., et al. Sleep apnoea in heart failure. Eur Respir J 29 6 (2007) 1201-1205
26. Oldenburg O., Lamp B., Faber L., et al. Sleep-disordered breathing in patients with symptomatic heart failure A contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Failure 9 (2007) 251-257
27. Vazir A., Hastings P.C., Dayer M., et al. A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Failure 9 (2007) 243-250
28. Zhao Z., Sullivan C., Liu Z., et al. Prevalence and clinical characteristics of sleep apnea in Chinese patients with heart failure. Int J Cardiol 118 (2007) 122-123
29. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 101 (2000) 392-397
30. Garrigue S., Pepin J.L., Defaye P., et al. High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation 115 13 (2007) 1703-1709
31. Feldman A.M., de Lissovoy G., Bristow M.R., et al. Cost effectiveness of cardiac resynchronization therapy in the comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) trial. J Am Coll Cardiol 46 (2005) 2311-2321
32. Lindenfeld J., Feldman A.M., Saxon L., et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation 115 (2007) 204-212
33. Sinha A.M., Skobel E.C., Breithardt O.A., et al. Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 44 (2004) 68-71
34. Oldenburg O., Faber L., Vogt J., et al. Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Fail 9 8 (2007) 820-826
35. Javaheri S. Sleep-related breathing disorders in heart failure. In: Heart failure, A companion to Braunwald's Heart Disease. Douglas L. Mann, editor. WB Saunders, Philadelphia, 2004;471-87.
36. Wuyam B., Pepin J.L., Tremel F., et al. Pathophysiology of central sleep apnea syndrome. Sleep 23 Suppl 4 (2000) S213-S219
37. Pepin J.L., Chouri-Pontarollo N., Tamisier R., et al. Cheyne-Stokes respiration with central sleep apnoea in chronic heart failure: proposals for a diagnostic and therapeutic strategy. Sleep Med Rev 10 (2006) 33-47
38. Javaheri S. Heart failure. In: Principles and practices of sleep medicine, 4/e; Kryger MH, Roth T, Dement WC, editors; WB Saunders, Philadelphia, 2005;1208-17.
39. Javaheri S., and Wexler L. Prevalence and treatment of breathing disorders during sleep in heart failure patients. Curr Treat Options Cardiovasc Med 7 (2005) 295-305
40. van de Borne P., Oren R., Abouassaly C., et al. Effect of Cheyne-Stokes respiration on muscle sympathetic nerve activity in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 81 (1998) 432-436
41. Solin P., Kaye D.M., Little P.J., et al. Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 123 (2003) 1119-1126
42. Leung R.S., Diep T.M., Bowman M.E., et al. Provocation of ventricular ectopy by Cheyne-Stokes respiration in patients with heart failure. Sleep 27 (2004) 1337-1343
43. Liston R., Deegan P.C., McCreery C., et al. Haemodynamic effects of nasal continuous positive airway pressure in severe congestive heart failure. Eur Respir J 8 (1995) 430-435